A decision guide, not a pharmacy

Why we built this

Most people arrive at weight-loss medication the same way: they’ve heard about “the jabs”, they’re curious, and within ten minutes of searching they’re buried in brand names, dose ladders and prices that refuse to line up. Two things make it harder than it should be. First, the medicines genuinely differ — a weekly dual-hormone injection, a weekly single-hormone injection with the longest track record, and now a daily tablet — and the right one depends on you, not on whichever advert got to you first. Second, every regulated UK provider sets its own price for the very same licensed medicine, and when we last checked, the gap on a single Mounjaro dose was £83 a month.

So we built the site we wished existed: a structured route from “I’ve heard about these” to a shortlist you can take into a consultation, followed by an honest table of what every provider charges.

How the site works

Everything follows the same if-this-then-that logic. The 60-second self-check narrows things down with three questions — needles, results, track record. The three paths lay out who each medicine tends to suit, with figures from the published trials rather than adjectives. And the comparison table lists every regulated provider we track, ranked by ongoing price.

Three rules keep the table honest:

• Price order is never for sale. Providers are ranked by what they charge. No provider can pay for a better position in the table.
• One clearly labelled pick. We pin a single recommended provider — currently The Weight Clinic — at the top, starred and labelled, for reasons we state plainly: monthly video reviews, a refund if the prescriber declines you, and a meaningful first-order discount. Below it, everyone competes on price.
• Regulated providers only. GPhC-registered pharmacies and CQC-regulated clinics dispensing licensed manufacturer stock. We will never list grey-market sellers or “compounded” imitations, and we’d rather warn you off them than pretend they don’t exist.

Editorially independent

The table is sorted by price and stays that way — no provider can pay to move up. We are editorially independent: our words are our own, and no provider reviews or approves what we publish.

What we are not

We are not a pharmacy, a clinic, or a source of medical advice. We do not sell, supply, prescribe or dispense anything. Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines with real side effects, and they are not suitable for everyone — whether one is right for you is a decision for a UK prescriber, informed by your GP or pharmacist. Our job ends where the consultation begins.

Keeping the numbers straight

Prices come from our provider dataset, checked against providers’ own published pages — most recently on 4 July 2026 — and every table shows its check date. Clinical figures come from the published trials (SURMOUNT, STEP, SELECT, OASIS) and UK guidance such as NICE’s recommendation of tirzepatide. Spot something stale or plain wrong? Tell us and we’ll fix it quickly.